UPM-Kymmene (UPM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 Oct, 2025Executive summary
Q3 2025 saw sales of €2,298 million, down 8.8–9% year-over-year, with comparable EBIT down 47% to €153 million but up 21–22% sequentially; EBIT margin was 6.7%.
Advanced Materials and Decarbonization Solutions showed resilience and improved performance, while Renewable Fibers and Communication Papers faced subdued demand and volatility.
Decisive actions included capacity closures, strategic partnerships, and a strategic review of the plywood business.
The Leuna biorefinery achieved industrial-scale production in its first core process, with first product sales expected in Q4 and full production and positive EBIT by 2027.
Sustainability recognitions included a Platinum EcoVadis rating and listings in major ESG indices.
Financial highlights
Q3 comparable EBIT: €153 million (6.7% of sales), up 21–22% sequentially but down 47% year-over-year.
Q3 2025 sales: €2,298 million (Q3 2024: €2,521 million); Q1–Q3 2025 sales: €7,344 million.
Operating cash flow: €218 million; net debt at €3,218 million; net debt/EBITDA: 2.36x.
Share buy-back of 6 million shares for €160 million; dividend of €1.50 per share for 2024.
Cash funds and committed credit facilities totaled €2.7–2.8 billion.
Outlook and guidance
H2 2025 comparable EBIT expected between €425–650 million (H1 2025: €413 million; H2 2024: €709 million).
Q4 performance to be supported by energy refunds and potential forest asset revaluation, but likely below last year.
Advanced materials expected to remain resilient; short-term Fibres performance sensitive to pulp prices and maintenance shutdowns.
Significant uncertainties remain due to geopolitics, trade relations, and currency fluctuations.
Weaker U.S. dollar and lower pulp margins expected to impact H2 2025.
Latest events from UPM-Kymmene
- Q4 2025 delivered strong cash flow and strategic actions despite lower sales and EBIT.UPM
Q4 20254 Feb 2026 - Q2 2024 EBIT up 60% year-over-year, with strong H2 outlook and major asset optimization.UPM
Q2 20243 Feb 2026 - Balanced global growth, strong cash flow, and sustainability drive future returns.UPM
CMD 202422 Jan 2026 - Q3 EBIT up 32% to EUR 291m, with cost actions and strategic moves supporting outlook.UPM
Q3 202418 Jan 2026 - Comparable EBIT up 21% to EUR 1,224m in 2024; H1 2025 EBIT seen at EUR 400–625m.UPM
Q4 20249 Jan 2026 - Comparable EBIT fell 14% as sales stayed flat and strategic actions continued amid uncertainty.UPM
Q1 202520 Dec 2025 - Joint venture valued at EUR 1.42bn to deliver EUR 100m annual synergies by end-2026.UPM
Partnership7 Dec 2025 - Q2 2025 earnings fell on lower prices and trade headwinds, but advanced materials and biofuels outperformed.UPM
Q2 20254 Nov 2025 - Balanced, sustainable portfolio with resilient advanced materials and biofuels amid trade headwinds.UPM
Investor Presentation29 Oct 2025